| Title: | The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992. |
| Author: | United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy |
| Note: | U.S. G.P.O. :, 1993 |
| Link: | page images at HathiTrust |
| No stable link: | This is an uncurated book entry from our extended bookshelves, readable online now but without a stable link here. You should not bookmark this page, but you can request that we add this book to our curated collection, which has stable links. |
| Subject: | Import quotas -- United States |
| Subject: | Medicine -- Research -- United States |
| Subject: | Mifepristone |
| Subject: | Mifepristone -- Government policy -- United States |
| Subject: | Pharmaceutical policy -- United States |
| Other copies: | Look for editions of this book at your library, or elsewhere. |
Help with reading books -- Report a bad link -- Suggest a new listing
Home -- Search -- New Listings -- Authors -- Titles -- Subjects -- Serials
Books -- News -- Features -- Archives -- The Inside Story
Edited by John Mark Ockerbloom (onlinebooks@pobox.upenn.edu)
OBP copyrights and licenses.